2016 Nov 09
Daedalus fund supports innovative cancer research
Two cancer center members were among seven selected for the third round of the Daedalus Fund for Innovation awards. Read more
2016 Nov 09
Trumping Science?
Harold Varmus, M.D., suggests that President-elect Trump and his advisors receive a science “tutorial” before taking office. Read more
2016 Nov 08
Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body's immune response
A team led by Doug Fearon, M.D., has traced cachexia to a molecular reprogramming of the liver induced by tumors, which also releases stress hormones that can prevent the immune system from responding. Read more
2016 Nov 08
Doctors should consider physiology of obese patients when designing cancer treatment
The metabolic state of patients influences their cancer risk, progression and response to treatment, warns researchers in the lab of Meyer director Lewis Cantley. Read more
2016 Nov 08
Breast cancer awards advance efforts to address metastasis and harness immune system
Two awards from the Department of Defense will help advance research into metastasis promoting protein Bcl-xL and immune response inhibiting adenosine. Read more
2016 Nov 05
Vitamin C kills tumor cells with hard-to-treat mutation
A new study echoes the findings of the Cantley Lab regarding the potential of Vitamin C as a cancer-killing therapy. Read more
2016 Nov 04
Nachman wins national mentorship award
Professor Emeritus Ralph Nachman, M.D., has won a 2016 Mentor Award from the American Society of Hematology for his commitment to training and mentoring early-career hematologists. Read more
2016 Nov 02
Why 121 years is too long to wait for gender parity in surgery
Heather Yeo, M.D., MPH, discusses the female surgeon experience and her growing role as an advocate. Read more
2016 Nov 02
National prostate biopsy and radical prostatectomy volumes decreased significantly following recommendation against PSA screening
A study by Jim Hu, M.D., and colleagues has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen (PSA) testing. Read more
2016 Nov 01
Shapeshifters in cancer
Feature about cancer resistance highlights the work of Himisha Beltran, M.D. Read more
2016 Nov 01
Pack-leading oncologist: Kristy Richards
Profile of Kristy Richards, M.D., Ph.D., and her work with lymphoma patients both canine and human. Read more
2016 Nov 01
Genomic Testing & Precision Medicine: Bigger Is Better
Olivier Elemento, Ph.D., and Mark Rubin, M.D., penned a guest piece in Oncology Times about genomics in oncology and the role of precision medicine Read more
2016 Oct 31
API-based genomics databank facilitates personalized medicine
Personalized medicine is getting a boost at Weill Cornell Medicine with an online genomics databank that uses an API to integrate insights into the clinical workflow. Read more
2016 Oct 28
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau, M.D., Ph.D. speaks about clonal evolution in chronic lymphocytic leukemia (CLL), after his talk at the 2016 International Workshop of the German CLL Study Group in Cologne, Germany. Read more
2016 Oct 28
Research identifies new target for cancer therapy
Epichaperomes’ that form in some cancer cells might enable selective therapies, according to research from Monica Guzman, Ph.D. Read more
2016 Oct 27
White adipose tissue inflammation in early-stage breast cancer
Inflammation of white adipose tissue may be a better predictor of breast cancer incomes than body mass index, according to Andrew Dannenberg, M.D. Read more
2016 Oct 26
Ending cancer as we know it
Rohan Ramakrishna, M.D., offers his analysis of the Cancer Moonshot Task Force recommendations. Read more
2016 Oct 25
$2M gift to drive Weill Cornell advances in immunotherapy
Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy. Read more
2016 Oct 24
Precision medicine is more than genomic sequencing
There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more
2016 Oct 21
Researchers tackle metastatic breast cancer
Linda Vahdat, M.D., appeared on CBS News to discuss her novel copper depletion therapy for metastatic breast cancer. Read more
